{"disease":{"id":"sphingolipidoses","name":"sphingolipidoses"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT02416661","title":"Lyso-Gb1 as a Long-term Prognostic Biomarker in Gaucher Disease","phase":"","overall_status":"COMPLETED","enrollment_count":299,"lead_sponsor_name":"CENTOGENE GmbH Rostock","has_results":false},{"nct_id":"NCT02171104","title":"MT2013-31: Allo HCT for Metabolic Disorders and Severe Osteopetrosis","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":149,"lead_sponsor_name":"Masonic Cancer Center, University of Minnesota","has_results":false},{"nct_id":"NCT04885179","title":"SPL Insufficiency Syndrome (SPLIS)/NPHS14: a SPLIS Observational Study and Patient Registry (International)","phase":"","overall_status":"RECRUITING","enrollment_count":120,"lead_sponsor_name":"University of California, San Francisco","has_results":false},{"nct_id":"NCT01963650","title":"Natural History Study of Children With Metachromatic Leukodystrophy","phase":"","overall_status":"TERMINATED","enrollment_count":1,"lead_sponsor_name":"Shire","has_results":false}],"total":4},"guidelines":[],"source":"Drug Landscape verified database"}